Illumaxbio, a leading provider of advanced in-vitro diagnostic solutions, made a splash at the China International Exhibition on In-vitro Diagnostics (CACLP2023) with the unveiling of its latest innovation – the world's smallest single-person flow cytometry platform, called P8. The platform, which measures less in height than a standard bottle of red wine and has a surface area equivalent to a large-format book, boasts exceptional performance and competitive advantages.
Compact and Powerful Design Draws Strong Interest from Users and Distributors
Within hours of its unveiling, P8 captured the attention of attendees and industry insiders alike, with more than ten distributors expressing interest in collaboration. P8's compact, sleek design and robust performance make it an ideal choice for individual researchers, small labs, and clinics, offering powerful flow cytometry results in a small, portable package.
Advanced R&D Capabilities and Full Supply Chain Enablement
Illumaxbio was able to leverage its extensive research and development capabilities in single-person chemiluminescence immunoassays and flow cytometry, spanning from core parts and raw materials design to machine and reagent development, full-scale production, quality control, product registration, and documentation. The company was able to achieve this full-chain capability thanks to its founding team's years of effort.
Open Ecosystem Based on Single-Person Flow Cytometry
Illumaxbio Founder, Mr. Xingpeng Zhang, announced at CACLP2023 his vision for an open ecosystem based on single-person chemiluminescence immunoassay and flow cytometry technologies, aimed at accelerating research and development of innovative assays and advancing precision diagnostics and personalized medicine.
Illumaxbio Draws Crowds with Fun Activities and Prizes
In addition to the debut of P8, Illumaxbio had an impressive presence at CACLP2023, with a booth filled with fun activities, interactive displays, and prizes. Attendees enjoyed getting hands-on with the latest product offerings while learning more about how Illumaxbio is driving advancement in the world of in-vitro diagnostics.
To learn more about Illumaxbio's latest products or explore partnership opportunities, please get in touch with us today.
Post time: Jun-09-2023
